US Stock MarketDetailed Quotes

ENSCW ENSYSCE BIOSCIENCES INC C/WTS 30/06/2026 (TO PUR COM)

Watchlist
  • 0.036
  • +0.014+63.18%
15min DelayClose Jun 17 16:00 ET
0Market Cap0.00P/E (TTM)

About ENSYSCE BIOSCIENCES INC C/WTS 30/06/2026 (TO PUR COM) Company

Ensysce Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of solutions for severe pain relief while reducing the fear of and the potential for misuse and overdose. The firm's Trypsin Activated Abuse Protection and Multi-Pill Abuse Resistance platforms are in the process of developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. The company was founded in April 2003 and is headquartered in La Jolla, CA.

Company Profile

SymbolENSCW
Company NameENSYSCE BIOSCIENCES INC C/WTS 30/06/2026 (TO PUR COM)
Listing DateDec 29, 2017
Founded2003
CEODr. D. Lynn Kirkpatrick, PhD
MarketPink Market
Employees9
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address7946 Ivanhoe Avenue,Suite 201
CityLa Jolla
ProvinceCalifornia
CountryUnited States of America
Zip Code92037
Phone1-858-263-4196

Company Executives

  • Name
  • Position
  • Salary
  • Dr. D. Lynn Kirkpatrick, PhD
  • President, Chief Executive Officer and Director
  • 622.61K
  • Geoffrey Birkett
  • Chief Commercial Officer
  • 366.96K
  • David Humphrey, C.P.A.
  • Chief Financial Officer, Principal Accounting Officer, Secretary and Treasurer
  • 780.62K
  • Linda Pestano, PhD
  • Chief Development Officer
  • --
  • Dr. William K. Schmidt, PhD
  • Chief Medical Officer
  • --
  • Dr. Jeffrey Millard, PhD
  • Chief Operating Officer
  • --
  • Dr. Bob G. Gower, PhD
  • Chairman of the Board
  • 48.95K
  • Dr. Adam S. Levin, M.D.
  • Independent Director
  • 33.95K
  • William Chang
  • Independent Director
  • 31.45K
  • Dr. Curtis Rosebraugh, M.D.
  • Independent Director
  • 31.45K
  • Steven R. Martin
  • Independent Director
  • 38.95K
  • Andrew Benton, J.D.
  • Independent Director
  • 31.45K
  • Lee Rauch
  • Independent Director
  • 36.93K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg